InterVenn Partners with Aranscia to Expand Ovarian Cancer Test Access
Multi-year agreement will provide clinical workflow software and laboratory support for GlycoKnow liquid biopsy test.
Multi-year agreement will provide clinical workflow software and laboratory support for GlycoKnow liquid biopsy test.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
University of Washington researchers find rapid test could improve treatment rates but may face implementation barriers due to reimbursement challenges.
The collaboration aims to unify data systems and automate workflows across pathology laboratories to address operational challenges.
The test is being developed to differentiate between adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis at the point of care.